S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)

Agile Therapeutics (AGRX) News Today

$1.95
+0.03 (+1.56%)
(As of 12/29/2023 ET)
SourceHeadline
MarketBeat logoAgile Therapeutics, Inc. (NASDAQ:AGRX) Short Interest Up 23.9% in December
americanbankingnews.com - December 31 at 3:56 AM
MarketBeat logoAgile Therapeutics (NASDAQ:AGRX) Share Price Passes Above 50 Day Moving Average of $2.03
americanbankingnews.com - December 27 at 4:20 AM
finance.yahoo.com logoAgile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage Requirement
finance.yahoo.com - December 12 at 9:19 AM
msn.com logoAgile Therapeutics reports Q3 results
msn.com - November 23 at 8:51 AM
benzinga.com logoAgile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024
benzinga.com - November 21 at 9:11 AM
markets.businessinsider.com logoAgile Therapeutics: A Promising Investment with Positive Cash Flow Forecasts and Anticipated Growth in Twirla Sales
markets.businessinsider.com - November 11 at 7:49 AM
finance.yahoo.com logoAgile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 10 at 10:58 AM
finance.yahoo.com logoAgile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - November 9 at 8:14 AM
msn.com logoAgile Therapeutics Q3 2023 Earnings Preview
msn.com - November 8 at 4:56 PM
finance.yahoo.com logoAgile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023
finance.yahoo.com - October 26 at 8:52 AM
finanznachrichten.de logoAgile Therapeutics, Inc.: Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
finanznachrichten.de - October 5 at 9:58 AM
finance.yahoo.com logoAgile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - October 4 at 6:38 PM
finanznachrichten.de logoAgile Therapeutics, Inc.: Agile Therapeutics Upgraded To "Buy" Rating By Analysts At Maxim Group
finanznachrichten.de - September 30 at 11:02 PM
finance.yahoo.com logoAgile Therapeutics (NASDAQ: AGRX) Upgraded To “Buy” Rating By Analysts At Maxim Group
finance.yahoo.com - September 28 at 12:55 PM
benzinga.com logoAgile Therapeutics (NASDAQ: AGRX) Upgraded To "Buy" Rating By Analysts At Maxim Group
benzinga.com - September 27 at 8:42 AM
finance.yahoo.com logoAgile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
finance.yahoo.com - September 5 at 5:38 PM
msn.com logoAgile ($AGRX) Says It's On Track To Hit $25-$30M Net Annual Revenue After A Strong Performance In Q2
msn.com - August 17 at 5:17 PM
finance.yahoo.com logoAgile Therapeutics, Inc. (NASDAQ:AGRX) Q2 2023 Earnings Call Transcript
finance.yahoo.com - August 11 at 6:10 PM
finanznachrichten.de logoAgile Therapeutics, Inc.: Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - August 9 at 9:07 PM
finance.yahoo.com logoAgile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - August 9 at 11:06 AM
finance.yahoo.com logoAgile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023
finance.yahoo.com - July 26 at 5:43 PM
finance.yahoo.com logoThis Reproductive Health Company's Weekly Contraceptive Patch Can Reach Millions of Women Thanks to a Partnership With Afaxys
finance.yahoo.com - July 19 at 12:50 PM
finanznachrichten.de logoAgile Therapeutics, Inc.: Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women
finanznachrichten.de - July 18 at 10:18 AM
msn.com logoNASDAQ: $AGRX Biden's Executive Order Boosts Adoption Of Agile Therapeutics' Contraceptive Patch
msn.com - July 18 at 10:18 AM
benzinga.com logoAgile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women
benzinga.com - July 14 at 9:46 AM
finance.yahoo.com logoAgile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Biden’s Latest Executive Order Expanding Contraceptive Coverage
finance.yahoo.com - July 11 at 1:38 PM
fool.com logoAgile Therapeutics (NASDAQ: AGRX)
fool.com - July 6 at 1:49 PM
finance.yahoo.com logoAgile Therapeutics Expects Its Innovative Once-A-Week Birth Control Patch To Drive Revenues Of $25-30 Million In 2023 - What Is The Hype All About?
finance.yahoo.com - June 30 at 9:40 AM
benzinga.com logoH.C. Wainwright Reiterates Buy Rating For Agile Therapeutics (NASDAQ: AGRX), Citing Growing Demand For Twirla, A Weekly Low Dose Birth Control Patch
benzinga.com - June 29 at 1:30 PM
finance.yahoo.com logoThe Overturning of Roe v. Wade Has Changed the Landscape of Birth Control; Smaller Companies are now an Integral Part of Care
finance.yahoo.com - June 28 at 9:33 AM
finance.yahoo.com logoPresident Biden’s new executive order could help American women get better birth control
finance.yahoo.com - June 27 at 8:47 PM
benzinga.com logoThis Women's Healthcare Company Raised $7.5 Million In A Public Offering And Says It's Targeting $25 To $30 Million Net Revenue By End Of 2023
benzinga.com - June 26 at 10:03 AM
finance.yahoo.com logoAgile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse Members
finance.yahoo.com - June 26 at 10:03 AM
finance.yahoo.com logoAgile Therapeutics Commends the Biden Administration’s Commitment to Strengthening Access to Affordable, High-Quality Contraception and Family Planning Services
finance.yahoo.com - June 23 at 2:40 PM
finance.yahoo.com logoAgile Therapeutics Announces the Availability of Twirla® through FPA Women’s Health
finance.yahoo.com - June 15 at 6:10 PM
msn.com logoAgile Therapeutics Rises on Teaming up with vitaCare for Expanding Twirla’s Reach
msn.com - June 14 at 12:24 PM
finance.yahoo.com logoWhy Agile Therapeutics Stock Is Trading Higher Today
finance.yahoo.com - June 14 at 12:24 PM
finance.yahoo.com logoAgile Therapeutics Announces New Agreement with vitaCare® Prescription Services to Improve Access to Twirla®
finance.yahoo.com - June 13 at 4:22 PM
markets.businessinsider.com logoAnalysts Have Conflicting Sentiments on These Healthcare Companies: Agile Therapeutics (AGRX), Check-Cap (CHEK) and Doximity (DOCS)
markets.businessinsider.com - June 8 at 6:23 PM
finanznachrichten.de logoAgile Therapeutics, Inc.: Agile Therapeutics Announces Closing of $7.5 Million Public Offering
finanznachrichten.de - May 26 at 7:52 AM
finance.yahoo.com logoAgile Therapeutics Announces Closing of $7.5 Million Public Offering
finance.yahoo.com - May 25 at 4:30 PM
msn.com logoAgile Therapeutics prices $7.5M offering
msn.com - May 23 at 7:43 AM
finance.yahoo.com logoAgile Therapeutics Announces Pricing of $7.5 Million Public Offering
finance.yahoo.com - May 22 at 9:29 PM
markets.businessinsider.com logoMaxim Group Sticks to Its Hold Rating for Agile Therapeutics (AGRX)
markets.businessinsider.com - May 13 at 8:58 PM
finance.yahoo.com logoQ1 2023 Agile Therapeutics Inc Earnings Call
finance.yahoo.com - May 12 at 9:16 AM
msn.com logoAgile Therapeutics: Q1 Earnings Insights
msn.com - May 11 at 11:11 PM
finance.yahoo.com logoAgile Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update
finance.yahoo.com - May 11 at 6:11 PM
finance.yahoo.com logoAgile Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update
finance.yahoo.com - May 11 at 6:11 PM
finance.yahoo.com logoAgile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023
finance.yahoo.com - May 8 at 10:03 AM
finance.yahoo.com logoAgile Therapeutics Announces Preliminary Expectations for First Quarter 2023
finance.yahoo.com - April 28 at 9:24 AM
Get Agile Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGRX and its competitors with MarketBeat's FREE daily newsletter.



AGRX Media Mentions By Week

AGRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AGRX
News Sentiment

0.51

0.84

Average
Medical
News Sentiment

AGRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AGRX Articles
This Week

4

1

AGRX Articles
Average Week

Get Agile Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:AGRX) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -